180 related articles for article (PubMed ID: 30878093)
1. Protective efficacy of liver fluke DNA vaccines: A systematic review and meta-analysis: Guiding novel vaccine development.
Jayaraj R; Kumarasamy C; Norbury L; Piedrafita D; Smooker P
Vet Parasitol; 2019 Mar; 267():90-98. PubMed ID: 30878093
[TBL] [Abstract][Full Text] [Related]
2. Protective role of purified cysteine proteinases against Fasciola gigantica infection in experimental animals.
El-Ahwany E; Rabia I; Nagy F; Zoheiry M; Diab T; Zada S
Korean J Parasitol; 2012 Mar; 50(1):45-51. PubMed ID: 22451733
[TBL] [Abstract][Full Text] [Related]
3. A novel ex vivo immunoproteomic approach characterising Fasciola hepatica tegumental antigens identified using immune antibody from resistant sheep.
Cameron TC; Cooke I; Faou P; Toet H; Piedrafita D; Young N; Rathinasamy V; Beddoe T; Anderson G; Dempster R; Spithill TW
Int J Parasitol; 2017 Aug; 47(9):555-567. PubMed ID: 28455238
[TBL] [Abstract][Full Text] [Related]
4. Immune response of rats vaccinated orally with various plant-expressed recombinant cysteine proteinase constructs when challenged with Fasciola hepatica metacercariae.
Kesik-Brodacka M; Lipiec A; Kozak Ljunggren M; Jedlina L; Miedzinska K; Mikolajczak M; Plucienniczak A; Legocki AB; Wedrychowicz H
PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005451. PubMed ID: 28333957
[TBL] [Abstract][Full Text] [Related]
5. Liver fluke vaccines in ruminants: strategies, progress and future opportunities.
Toet H; Piedrafita DM; Spithill TW
Int J Parasitol; 2014 Oct; 44(12):915-27. PubMed ID: 25200351
[TBL] [Abstract][Full Text] [Related]
6. Identification of protective peptides of Fasciola hepatica-derived cathepsin L1 (FhCL1) in vaccinated sheep by a linear B-cell epitope mapping approach.
Buffoni L; Garza-Cuartero L; Pérez-Caballero R; Zafra R; Javier Martínez-Moreno F; Molina-Hernández V; Pérez J; Martínez-Moreno Á; Mulcahy G
Parasit Vectors; 2020 Jul; 13(1):390. PubMed ID: 32736582
[TBL] [Abstract][Full Text] [Related]
7. Fasciola antigens as vaccines against fascioliasis and schistosomiasis.
Hillyer GV
J Helminthol; 2005 Sep; 79(3):241-7. PubMed ID: 16153318
[TBL] [Abstract][Full Text] [Related]
8. Antibody recognition of cathepsin L1-derived peptides in Fasciola hepatica-infected and/or vaccinated cattle and identification of protective linear B-cell epitopes.
Garza-Cuartero L; Geurden T; Mahan SM; Hardham JM; Dalton JP; Mulcahy G
Vaccine; 2018 Feb; 36(7):958-968. PubMed ID: 29373193
[TBL] [Abstract][Full Text] [Related]
9. Lack of protective efficacy in buffaloes vaccinated with Fasciola gigantica leucine aminopeptidase and peroxiredoxin recombinant proteins.
Raina OK; Nagar G; Varghese A; Prajitha G; Alex A; Maharana BR; Joshi P
Acta Trop; 2011 Jun; 118(3):217-22. PubMed ID: 21376699
[TBL] [Abstract][Full Text] [Related]
10. Immune responses in rats and sheep induced by a DNA vaccine containing the phosphoglycerate kinase gene of Fasciola hepatica and liver fluke infection.
Wesołowska A; Zawistowska-Deniziak A; Norbury LJ; Wilkowski P; Januszkiewicz K; Pyziel AM; Zygner W; Wędrychowicz H
Acta Parasitol; 2016 Mar; 61(2):212-20. PubMed ID: 27078643
[TBL] [Abstract][Full Text] [Related]
11. Vaccine potential of inclusion bodies containing cysteine proteinase of Fasciola hepatica in calves and lambs experimentally challenged with metacercariae of the fluke.
Wedrychowicz H; Kesik M; Kaliniak M; Kozak-Cieszczyk M; Jedlina-Panasiuk L; Jaros S; Plucienniczak A
Vet Parasitol; 2007 Jun; 147(1-2):77-88. PubMed ID: 17481823
[TBL] [Abstract][Full Text] [Related]
12. The failure of a DNA prime/protein boost regime and CTLA-4 mediated targeting to improve the potency of a DNA vaccine encoding Fasciola hepatica phosphoglycerate kinase in sheep.
Wesołowska A; Basałaj K; Zawistowska-Deniziak A; Januszkiewicz K; Kozak Ljunggren M; Jedlina L; Wędrychowicz H
Vet Immunol Immunopathol; 2019 Nov; 217():109941. PubMed ID: 31550657
[TBL] [Abstract][Full Text] [Related]
13. Vaccination against Fasciola hepatica using cathepsin L3 and B3 proteases delivered alone or in combination.
Wesołowska A; Basałaj K; Norbury LJ; Sielicka A; Wędrychowicz H; Zawistowska-Deniziak A
Vet Parasitol; 2018 Jan; 250():15-21. PubMed ID: 29329618
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the immune response of male and female rats vaccinated with cDNA encoding a cysteine proteinase of Fasciola hepatica (FhPcW1).
Wesołowska A; Norbury LJ; Januszkiewicz K; Jedlina L; Jaros S; Zawistowska-Deniziak A; Zygner W; Wędrychowicz H
Acta Parasitol; 2013 Jun; 58(2):198-206. PubMed ID: 23666656
[TBL] [Abstract][Full Text] [Related]
15. Blocking Fasciola hepatica's energy metabolism - a pilot study of vaccine potential of a novel gene - phosphoglycerate kinase.
Jaros S; Jaros D; Wesolowska A; Zygner W; Wedrychowicz H
Vet Parasitol; 2010 Sep; 172(3-4):229-37. PubMed ID: 20538413
[TBL] [Abstract][Full Text] [Related]
16. Fasciola hepatica antioxidant and protease-inhibitor cocktail recombinant vaccines administered five times elicit potent and sustained immune responses in sheep but do not confer protection.
Cwiklinski K; McEvoy A; López Corrales J; Jewhurst H; Calvani NED; De Marco Verissimo C; Dorey AL; Keane OM; Dalton JP; Lalor R
Vet Parasitol; 2023 Nov; 323():110049. PubMed ID: 37826973
[TBL] [Abstract][Full Text] [Related]
17. Fasciola hepatica cathepsin L-like proteases: biology, function, and potential in the development of first generation liver fluke vaccines.
Dalton JP; Neill SO; Stack C; Collins P; Walshe A; Sekiya M; Doyle S; Mulcahy G; Hoyle D; Khaznadji E; Moiré N; Brennan G; Mousley A; Kreshchenko N; Maule AG; Donnelly SM
Int J Parasitol; 2003 Sep; 33(11):1173-81. PubMed ID: 13678633
[TBL] [Abstract][Full Text] [Related]
18. A Preliminary Study of a Lettuce-Based Edible Vaccine Expressing the Cysteine Proteinase of
Wesołowska A; Kozak Ljunggren M; Jedlina L; Basałaj K; Legocki A; Wedrychowicz H; Kesik-Brodacka M
Front Immunol; 2018; 9():2592. PubMed ID: 30483259
[TBL] [Abstract][Full Text] [Related]
19. Sex and vaccination: Insights from female rats vaccinated with juvenile-specific proteases from Fasciola hepatica.
Wesołowska A; Basałaj K; Norbury LJ; Sielicka A; Wędrychowicz H; Zawistowska-Deniziak A
Vet Parasitol; 2018 May; 255():91-96. PubMed ID: 29773143
[TBL] [Abstract][Full Text] [Related]
20. Low allelic diversity in vaccine candidates genes from different locations sustain hope for Fasciola hepatica immunization.
Dominguez MF; González-Miguel J; Carmona C; Dalton JP; Cwiklinski K; Tort J; Siles-Lucas M
Vet Parasitol; 2018 Jul; 258():46-52. PubMed ID: 30105977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
